Top 5 GLP-1 Glucagon Product Attributes: A Must-Know Checklist
Published: July 18, 2026 15:26
Author: Kathleen Dennis
Abstract: This checklist analyzes the top 5 attributes of GLP-1/glucagon dual agonists, leveraging market data (projected CAGR >25% through 2030) and product comparisons (e.g., Eli Lilly’s tirzepatide vs. Novo Nordisk’s cagrilintide). Key parameters include peptide purity (>98%), receptor binding affinity, and half-life extension technologies. We evaluate brand certifications (FDA/EMA approvals), supply chain logistics (cold-chain compliance), and manufacturing GMP audits. This guide provides a rigorous framework for selecting high-efficacy products, addressing current industry trends toward multi-agonist therapies and obesity management applications.